These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 29894486
1. Mycosis fungoides progression could be regulated by microRNAs. Manso R, Martínez-Magunacelaya N, Eraña-Tomás I, Monsalvez V, Rodríguez-Peralto JL, Ortiz-Romero PL, Santonja C, Cristóbal I, Piris MA, Rodríguez-Pinilla SM. PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486 [Abstract] [Full Text] [Related]
2. miRNA expression profiling of mycosis fungoides. van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, van Doorn R, Vermeer MH, Willemze R, Tensen CP, Lawrie CH. Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335 [Abstract] [Full Text] [Related]
3. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, Marstrand T, Fredholm S, Iversen L, Wasik MA, Bonefeld CM, Geisler C, Krejsgaard T, Glue C, Røpke MA, Woetmann A, Skov L, Grønbæk K, Odum N. Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151 [Abstract] [Full Text] [Related]
5. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications. Alcántara-Hernández M, Torres-Zárate C, Pérez-Montesinos G, Jurado-Santacruz F, Domínguez-Gómez MA, Peniche-Castellanos A, Ferat-Osorio E, Neri N, Nambo MJ, Alvarado-Cabrero I, Moreno-Lafont M, Huerta-Yepez S, Bonifaz LC. Int J Cancer; 2014 May 01; 134(9):2136-45. PubMed ID: 24127318 [Abstract] [Full Text] [Related]
6. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides. Garaicoa FH, Roisman A, Arias M, Trila C, Fridmanis M, Abeldaño A, Vanzulli S, Narbaitz M, Slavutsky I. Tumour Biol; 2016 Oct 01; 37(10):13637-13647. PubMed ID: 27473081 [Abstract] [Full Text] [Related]
9. Molecular markers of early-stage mycosis fungoides. Zhang Y, Wang Y, Yu R, Huang Y, Su M, Xiao C, Martinka M, Dutz JP, Zhang X, Zheng Z, Zhou Y. J Invest Dermatol; 2012 Jun 01; 132(6):1698-706. PubMed ID: 22377759 [Abstract] [Full Text] [Related]
10. Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms. Avgeros C, Patsatsi A, Dimitriadis D, Malousi A, Koletsa T, Papathemeli D, Syrnioti A, Avgerou P, Lazaridou E, Tzimagiorgis G, Georgiou E. Int J Mol Sci; 2022 Dec 23; 24(1):. PubMed ID: 36613718 [Abstract] [Full Text] [Related]
18. Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis. Wada DA, Wilcox RA, Weenig RH, Gibson LE. J Cutan Pathol; 2010 May 23; 37(5):535-41. PubMed ID: 19674197 [Abstract] [Full Text] [Related]
19. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing. Moyal L, Gorovitz-Haris B, Yehezkel S, Jacob-Hirsch J, Bershtein V, Barzilai A, Rotem C, Sherman S, Amitay-Laish I, Feinmesser M, Hodak E. Br J Dermatol; 2019 May 23; 180(5):1123-1134. PubMed ID: 30431147 [Abstract] [Full Text] [Related]
20. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides. Daggett RN, Kurata M, Abe S, Onishi I, Miura K, Sawada Y, Tanizawa T, Kitagawa M. Br J Dermatol; 2014 Oct 23; 171(4):722-31. PubMed ID: 24725174 [Abstract] [Full Text] [Related] Page: [Next] [New Search]